These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12153750)
21. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237 [TBL] [Abstract][Full Text] [Related]
22. The somatostatin analogue octreotide modulates Iodothyronine deiodinase activity and pituitary neuromedin B. Curty FH; Lisbôa PC; Ortiga-Carvalho TM; Pazos-Moura CC Thyroid; 2000 Aug; 10(8):647-52. PubMed ID: 11014308 [TBL] [Abstract][Full Text] [Related]
23. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. Salvatore D; Tu H; Harney JW; Larsen PR J Clin Invest; 1996 Aug; 98(4):962-8. PubMed ID: 8770868 [TBL] [Abstract][Full Text] [Related]
24. Rat brain type II 5'-iodothyronine deiodinase activity is extremely sensitive to stress. Baumgartner A; Hiedra L; Pinna G; Eravci M; Prengel H; Meinhold H J Neurochem; 1998 Aug; 71(2):817-26. PubMed ID: 9681474 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary. Rotondo F; Kovacs K; Scheithauer BW; Horvath E; Bell CD; Lloyd RV; Cusimano M Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):477-81. PubMed ID: 18633321 [TBL] [Abstract][Full Text] [Related]
26. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. Pagotto U; Marsicano G; Fezza F; Theodoropoulou M; Grübler Y; Stalla J; Arzberger T; Milone A; Losa M; Di Marzo V; Lutz B; Stalla GK J Clin Endocrinol Metab; 2001 Jun; 86(6):2687-96. PubMed ID: 11397872 [TBL] [Abstract][Full Text] [Related]
27. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture. Yamaji T; Ishibashi M; Teramoto A; Fukushima T Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725 [TBL] [Abstract][Full Text] [Related]
28. Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats. Fernandez-Ruiz JJ; Esquifino AI; Steger RW; Amador AG; Bartke A Brain Res; 1987 Sep; 421(1-2):65-8. PubMed ID: 2891404 [TBL] [Abstract][Full Text] [Related]
29. Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. Visser TJ; Kaplan MM; Leonard JL; Larsen PR J Clin Invest; 1983 Apr; 71(4):992-1002. PubMed ID: 6833498 [TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163 [TBL] [Abstract][Full Text] [Related]
32. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H; Saeger W Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [TBL] [Abstract][Full Text] [Related]
33. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas. Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804 [TBL] [Abstract][Full Text] [Related]
34. Pituitary adenomas: immunohistology and ultrastructural analysis of 118 tumors. Esiri MM; Adams CB; Burke C; Underdown R Acta Neuropathol; 1983; 62(1-2):1-14. PubMed ID: 6318500 [TBL] [Abstract][Full Text] [Related]
35. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Oyama K; Sanno N; Teramoto A; Osamura RY Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786 [TBL] [Abstract][Full Text] [Related]
36. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Schneider MJ; Fiering SN; Pallud SE; Parlow AF; St Germain DL; Galton VA Mol Endocrinol; 2001 Dec; 15(12):2137-48. PubMed ID: 11731615 [TBL] [Abstract][Full Text] [Related]
37. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas. Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894 [TBL] [Abstract][Full Text] [Related]
38. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Alvaro V; Touraine P; Raisman Vozari R; Bai-Grenier F; Birman P; Joubert D Int J Cancer; 1992 Mar; 50(5):724-30. PubMed ID: 1347514 [TBL] [Abstract][Full Text] [Related]
39. Thyroxine 5'-deiodinase activity in anterior pituitary glands transplanted under the renal capsule in the rat. St Germain DL; Adler RA; Galton VA Endocrinology; 1985 Jul; 117(1):55-63. PubMed ID: 4006866 [TBL] [Abstract][Full Text] [Related]
40. The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas. Warnet A Metabolism; 1992 Sep; 41(9 Suppl 2):59-61. PubMed ID: 1325596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]